Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus

Journal of Hepatology

Volumn 32, Issue 1, 2000, Pages 126-134

  Doughty, Alison L ^a   Painter, Dorothy M ^a   McCaughan, Geoffrey W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cholestatic hepatitis; Liver transplantation; Quasispecies; Recurrent hepatitis C virus; SSCP

Indexed keywords

ANTIBODY; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; VIRUS RNA;

ADULT; ARTICLE; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS LOAD;

EID: 0033957537     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80199-3     Document Type: Article

References (40)

1. Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP, Mills AS, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orthopic liver transplantation. Transplantation. 57:1994;526-532.
2. Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol. 22:(Suppl):1995;154S-159S.
3. Boker KHW, Dalley G, Bahr MJ, Machek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 25:1997;203-210.
4. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology. 20:(Suppl):1994;24S-27S.
5. Gane EJ, Naoumov NV, Quian KP, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 110:1996;167-177.
6. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transplant Surg. 4:1998;15-21.
7. Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
8. Dickson RC, Caldwell SH, Ishitani MB, Lau JYN, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to reccurrent hepatitis C in four patients after liver transplantation. Transplantation. 61:1996;701-705.
9. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD. Cholestatic hepatitis C in liver allografts. Liver Transplant Surg. 4:1998;304-310.
10. Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JY. Cholestatic hepatitis leading to hepatic failure in a patient with organ transmitted hepatitis C virus infection. Gastroenterology. 106:1994;248-251.
11. Mason AL, Wick M, White HM, Benner KG, Regenstein F, Riely CA, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology. 105:1993;237-244.
12. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology. 20:1994;1144-1151.
13. Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. J Infect Dis. 172:1995;261-264.
14. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology. 22:1995;30-35.
15. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology. 25:1997;697-701.
16. Gonzalez-Peralta RP, She JY, Davis GL, Ohno T, Mizokami M, Lau JYN. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol. 49:1996;242-247.
17. Yuki N, Hayashi N, Moribe T, Matsushita Y, Tabata T, Inoue T, et al. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology. 25:1997;439-444.
18. Brambilla S, Bellati G, Asti M, Lisa A, Candusso ME, D'Amico M, et al. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology. 27:1998;1678-1686.
19. Leone F, Zylberberg H, Squadrito G, Le Guen B, Berthelot P, Pol S, et al. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection. J Hepatol. 29:1998;689-694.
20. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol. 68:1994;3425-3436.
21. Yun Z, Barkholt L, Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation. 64:1997;170-172.
22. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol. 70:1996;7622-7631.
23. Lawal Z, Petrik J, Wong VS, Alexander GJM, Allain JP. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology. 228:1997;107-111.
24. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:1991;842-848.
25. Weiner AJ, Geysen HM, Christophersen C, Hall JE, Mason TJ, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. PNAS. 89:1992;3468-3472.
26. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of hepatitis C virus. PNAS. 88:1991;2451-2455.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
28. Wilson JJ, Polyak SJ, Day TD, Gretch DR. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol. 76:1995;1763-1771.
29. Lis JT. Fractionation of DNA fragments by polyethylene induced precipitation. Meth Enzymol. 65:1980;347-353.
30. Thompson JD, Higgins DG, Gibson TJ, Clustal W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res. 22:1984;4673-4680.
31. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nuc Acids Res. 12:1984;387-395.
32. Felsenstein J. Phylip manual. University of Washington, Seattle. 1990.
33. Page RDM. TREEVIEW: an application to display phylogenetic trees on personal computers. Comput Appl Biosci. 12:1996;357-358.
34. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet. 48:1991;137-144.
35. Chen JJ, McGuinness P, Rickard K, Koorey D, Viley B, McCaughan GW. Hepatitis C genotypes in a cohort of blood donors, haemophiliacs and liver transplantation patients. J Gastro Hepatol. 12:1997;182-187.
36. Gretch DR, Sullivan DG, Stuart M, Shelton D, Larson A, Carithers RL. High viral load and reduced quasispecies divergence correlate with severe disease in post-transplant hepatitis C: implications for post-transplant management. [abstract] Hepatology. 28:1998;314A.
37. Naito M, Hayashi N, Moribe T, Hagiwara H, Mita E, Kanazawa Y, et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology. 22:1995;407-412.
38. DiMartino V, Saurini F, Samuel D, Gigi U, Dussaix E, Reynes M, et al. Long term longitudinal study of intrahepatic hepatitis C virus replicatiion after liver transplantation. Hepatology. 26:1997;1343-1350.
39. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 28:1998;823-830.
40. McCaughan GW, Napoli J, McGuinness P, Bishop GA. T1 vs T2 cytokine responses in chronic HCV: implications on the mechanisms of liver injury. Viral Hep. 3:1997;129-142.